Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
Abstract
A robust personalized ctDNA test, TARDIS, achieves high accuracy for residual disease after completion of neoadjuvant...
Paper Details
Title
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
Published Date
Aug 7, 2019
Volume
11
Issue
504
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History